Neuroblastoma Latest Advances

Spatially resolved T cell receptor tracking reveals γδT cell localization to tumor-rich regions in high-risk neuroblastoma: A Report from the Children's Oncology Group.

Journal: medRxiv : the preprint server for health sciences

Published: June 22, 2026

Eflornithine for neuroblastoma.

Journal: Australian prescriber

Published: June 18, 2026

Compressive Optic Neuropathy Secondary to Metastatic Neuroblastoma.

Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

Published: June 15, 2026

Molecular Imaging Tools for Improved Risk Stratification of Pediatric Neuroblastoma.

Journal: Radiology. Imaging cancer

Published: June 12, 2026

A Novel Therapeutic Approach: Gamma Secretase Inhibitor Enhances Radiotherapy and Checkpoint Blockade Therapy via Reprogramming of the Tumor Microenvironment.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2026

Advances in Neuroblastoma and Wilms Tumor.

Journal: Hematology/oncology clinics of North America

Published: June 10, 2026

Strand-specific quantification of L1 ORF0 and related transcripts by multiplex reverse transcription with tagged primers.

Journal: BioTechniques

Published: June 08, 2026

Zika virus as an oncolytic therapy.

Journal: Advances in cancer research

Published: June 05, 2026

Molecular-Structural MRI Mismatch for Preoperative Risk Stratification of Pediatric Neuroblastoma.

Journal: Radiology. Imaging cancer

Published: June 05, 2026

Peri-operative management of a child with catecholamine-secreting neuroblastoma and Dravet syndrome undergoing tumour resection.

Journal: Anaesthesia reports

Published: June 04, 2026

Feasibility and Nurse Acceptability of Dexmedetomidine Use During I-131 MIBG Therapy in Pediatric Patients With Neuroblastoma.

Journal: Journal of pediatric hematology/oncology nursing

Published: June 04, 2026

Correction: Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents.

Journal: Cell death & disease

Published: June 02, 2026

Neuroblastoma Latest Advances

Find the Latest Research About Neuroblastoma

Spatially resolved T cell receptor tracking reveals γδT cell localization to tumor-rich regions in high-risk neuroblastoma: A Report from the Children's Oncology Group.

Spatially resolved T cell receptor tracking reveals γδT cell localization to tumor-rich regions in high-risk neuroblastoma: A Report from the Children's Oncology Group.

Eflornithine for neuroblastoma.

Eflornithine for neuroblastoma.

Compressive Optic Neuropathy Secondary to Metastatic Neuroblastoma.

Compressive Optic Neuropathy Secondary to Metastatic Neuroblastoma.

Molecular Imaging Tools for Improved Risk Stratification of Pediatric Neuroblastoma.

Molecular Imaging Tools for Improved Risk Stratification of Pediatric Neuroblastoma.

A Novel Therapeutic Approach: Gamma Secretase Inhibitor Enhances Radiotherapy and Checkpoint Blockade Therapy via Reprogramming of the Tumor Microenvironment.

A Novel Therapeutic Approach: Gamma Secretase Inhibitor Enhances Radiotherapy and Checkpoint Blockade Therapy via Reprogramming of the Tumor Microenvironment.

Advances in Neuroblastoma and Wilms Tumor.

Advances in Neuroblastoma and Wilms Tumor.

Strand-specific quantification of L1 ORF0 and related transcripts by multiplex reverse transcription with tagged primers.

Strand-specific quantification of L1 ORF0 and related transcripts by multiplex reverse transcription with tagged primers.

Zika virus as an oncolytic therapy.

Zika virus as an oncolytic therapy.

Molecular-Structural MRI Mismatch for Preoperative Risk Stratification of Pediatric Neuroblastoma.

Molecular-Structural MRI Mismatch for Preoperative Risk Stratification of Pediatric Neuroblastoma.

Peri-operative management of a child with catecholamine-secreting neuroblastoma and Dravet syndrome undergoing tumour resection.

Peri-operative management of a child with catecholamine-secreting neuroblastoma and Dravet syndrome undergoing tumour resection.

Feasibility and Nurse Acceptability of Dexmedetomidine Use During I-131 MIBG Therapy in Pediatric Patients With Neuroblastoma.

Feasibility and Nurse Acceptability of Dexmedetomidine Use During I-131 MIBG Therapy in Pediatric Patients With Neuroblastoma.

Correction: Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents.

Correction: Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents.